Diagnostic Value of Differential Expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in Benign and Malignant Follicular-Derived Lesions of the Thyroid: An Immunohistochemical Tissue Microarray Analysis
- 1 January 2006
- journal article
- Published by Springer Nature in Endocrine Pathology
- Vol. 17 (3) , 225-234
- https://doi.org/10.1385/ep:17:3:225
Abstract
Background Several immunohistochemical markers have been used to aid in the diagnosis of follicular-derived lesions of the thyroid (FDLT). In this study we analyze the diagnostic efficacy of an...Keywords
This publication has 44 references indexed in Scilit:
- The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membraneEndocrine-Related Cancer, 2006
- Usefulness of HBME‐1, cytokeratin 19 and galectin‐3 immunostaining in the diagnosis of thyroid malignancyHistopathology, 2005
- Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potentialLaboratory Investigation, 2005
- The Na+/I− Symporter Mediates Iodide Uptake in Breast Cancer Metastases and Can Be Selectively Down-Regulated in the ThyroidClinical Cancer Research, 2004
- Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)‐like nuclear alterations express molecular markers of PTCHistopathology, 2004
- HBME-1 y ciclina D1: marcadores diagnósticos de carcinoma folicular del tiroidesRevista médica de Chile, 2004
- The Quest for a Magic Tumor MarkerAmerican Journal of Clinical Pathology, 2002
- Follicular-Patterned Lesions of the ThyroidAmerican Journal of Clinical Pathology, 2002
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Guest Editorial: Two Proposals Regarding the Terminology of Thyroid TumorsInternational Journal of Surgical Pathology, 2000